HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.

AuthorsP J Henslee, V S Byers, C D Jennings, E Marciniak, J S Thompson, J S Macdonald, E H Romond, M J Messino, P J Scannon
JournalTransplantation proceedings (Transplant Proc) Vol. 21 Issue 1 Pt 3 Pg. 3004-7 (Feb 1989) ISSN: 0041-1345 [Print] United States
PMID2650413 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Immunotoxins
  • zolimomab aritox
  • Ricin
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Bone Marrow Transplantation (immunology)
  • Drug Evaluation
  • Graft vs Host Disease (immunology, prevention & control)
  • Histocompatibility Testing
  • Humans
  • Immunotoxins (therapeutic use)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (immunology, surgery, therapy)
  • Lymphocyte Depletion
  • Male
  • Postoperative Complications (prevention & control)
  • Ricin (immunology, therapeutic use)
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: